Skip to main content
logo
Silence Therapeutics plc (SLNCF)
OTCMKTS · Delayed Price · Currency is USD
6.36
0.00 (0.00%)
At close: Nov 6, 2026

Silence Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
1,229287325672547715
Market Cap Growth
316.81%-11.59%-51.64%22.71%-23.44%17.04%
Enterprise Value
1,157185152600448612
Last Close Price
6.362.002.631.503.257.15

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
1997.58513.747.5121.2325.2842.53
PB Ratio
31.934.612.4230.5420.5861.93
P/TBV Ratio
44.025.592.6157.6633.06580.25
P/FCF Ratio
-----96.09
P/OCF Ratio
-----77.58

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
-331.263.5218.9720.6736.40
EV/FCF Ratio
-----82.24

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.000.000.000.020.020.02
Debt / FCF Ratio
-----0.03
Net Debt / Equity Ratio
-1.87-1.36-1.10-3.11-3.20-8.61
Net Debt / EBITDA Ratio
1.131.043.011.321.681.61
Net Debt / FCF Ratio
1.701.362.171.381.49-13.36
Asset Turnover
0.010.000.270.250.180.14
Quick Ratio
6.408.0610.364.154.035.41
Current Ratio
7.428.7211.144.624.415.69
Return on Equity (ROE)
-90.41%-90.27%-58.08%-223.22%-273.06%-448.22%
Return on Assets (ROA)
-29.65%-30.79%-19.24%-26.32%-26.09%-31.44%
Return on Capital Employed (ROCE)
-68.80%-69.80%-26.70%-54.00%-49.70%-56.50%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-6.66%-30.86%-13.95%-8.07%-9.20%-7.46%
FCF Yield
-3.44%-21.70%-20.89%-7.37%-10.45%1.04%
Buyback Yield / Dilution
-0.09%-2.12%-24.69%-15.21%-8.58%-8.78%